RxSight (RXST) EBT (2020 - 2026)
RxSight (RXST) posted EBT of -$15.9 million for Q1 2026, down 73.59% on a QoQ basis from -$9.1 million in Q4 2025, and down 94.3% year-over-year from -$278.4 million in Q1 2025.
RxSight (RXST) EBT (2020 - 2026) Analysis & Trends
RxSight's EBT history runs 7 years deep, the most recent figure standing at -$15.9 million for Q1 2026.
- Quarterly EBT fell 94.3% year-over-year to -$15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.6 million (down 75.89% YoY) and the FY2025 annual result came in at -$38.9 million, down 41.86% from the prior year.
- EBT was -$15.9 million for Q1 2026 at RxSight, down from -$9.1 million in the prior quarter.
- Across five years, EBT topped out at $51.1 million in Q4 2022 and bottomed at -$17.6 million in Q1 2022.
- A 5-year average of -$4.8 million and a median of -$9.8 million in 2025 frame the typical range for EBT.
- Peak annual rise in EBT reached 425.1% in 2022, while the deepest fall reached 158.78% in 2022.
- RxSight's EBT stood at $51.1 million in 2022, then dropped by 22.97% to $39.4 million in 2023, then slumped by 115.04% to -$5.9 million in 2024, then plunged by 54.35% to -$9.1 million in 2025, then plunged by 73.59% to -$15.9 million in 2026.
- Business Quant data shows RXST's EBT at -$15.9 million in Q1 2026, -$9.1 million in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -15.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.88 Mn |
| Dec 31, 2025 | -9.15 Mn |
| Sep 30, 2025 | -9.81 Mn |
| Jun 30, 2025 | -11.75 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -5.93 Mn |
| Sep 30, 2024 | -6.33 Mn |
| Jun 30, 2024 | -6.06 Mn |
| Mar 31, 2024 | -9.09 Mn |
| Dec 31, 2023 | 39.40 Mn |
| Sep 30, 2023 | -12.40 Mn |
| Jun 30, 2023 | -13.78 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | 51.15 Mn |
| Sep 30, 2022 | -16.82 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.59 Mn |
| Dec 31, 2021 | -15.73 Mn |
| Sep 30, 2021 | -12.68 Mn |
| Jun 30, 2021 | -13.47 Mn |